Trillium Therapeutics (Trillium Therapeutics) Other Current Payables : $0.13 Mil (As of Sep. 2021)

View and export this data going back to 2009. Start your Free Trial

What is Trillium Therapeutics Other Current Payables?

Trillium Therapeutics's Other Current Payables for the quarter that ended in Sep. 2021 was $0.13 Mil.

Trillium Therapeutics's quarterly Other Current Payables increased from Mar. 2021 ($0.09 Mil) to Jun. 2021 ($0.12 Mil) and increased from Jun. 2021 ($0.12 Mil) to Sep. 2021 ($0.13 Mil).

Trillium Therapeutics's annual Other Current Payables increased from Dec. 2018 ($0.66 Mil) to Dec. 2019 ($2.78 Mil) but then declined from Dec. 2019 ($2.78 Mil) to Dec. 2020 ($0.04 Mil).

Trillium Therapeutics Other Current Payables Historical Data

The historical data trend for Trillium Therapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trillium Therapeutics Other Current Payables Chart

Trillium Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Other Current Payables

Get a 7-Day Free Trial

0.33

0.66

2.78

0.04

Trillium Therapeutics Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Other Current Payables	Get a 7-Day Free Trial															-	0.04	0.09	0.12	0.13

Trillium Therapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Trillium Therapeutics Other Current Payables Related Terms

Thank you for viewing the detailed overview of Trillium Therapeutics's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Trillium Therapeutics (Trillium Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trillium Therapeutics Inc (NAS:TRIL) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 CambridgePark Drive, Suite 510, Cambridge, MA, USA, 02140

Website

https://www.trilliumtherapeutics.com

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.